Kodiak Sciences Inc. (KOD)
USD 4.8
(6.9%)
USD 4.8
(6.9%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 181.63 Million USD | 107.03% |
| 2022 | 87.73 Million USD | 9.67% |
| 2021 | 79.99 Million USD | 3.35% |
| 2020 | 77.4 Million USD | 3900.1% |
| 2019 | 1.93 Million USD | 0.0% |
| 2018 | - USD | -100.0% |
| 2017 | 10.08 Million USD | 5349.73% |
| 2016 | 185 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 175.75 Million USD | -57.52% |
| 2024 Q1 | 178.32 Million USD | -1.82% |
| 2023 Q3 | 83.47 Million USD | -1.55% |
| 2023 Q1 | 86.75 Million USD | -1.12% |
| 2023 FY | 181.63 Million USD | 107.03% |
| 2023 Q4 | 181.63 Million USD | 117.59% |
| 2023 Q2 | 84.79 Million USD | -2.26% |
| 2022 Q2 | 87.02 Million USD | 6.92% |
| 2022 Q4 | 87.73 Million USD | -0.11% |
| 2022 Q1 | 81.39 Million USD | 1.75% |
| 2022 FY | 87.73 Million USD | 9.67% |
| 2022 Q3 | 87.83 Million USD | 0.92% |
| 2021 Q1 | 77.65 Million USD | 0.33% |
| 2021 FY | 79.99 Million USD | 3.35% |
| 2021 Q4 | 79.99 Million USD | 1.32% |
| 2021 Q3 | 78.95 Million USD | 0.9% |
| 2021 Q2 | 78.25 Million USD | 0.76% |
| 2020 Q3 | 77.32 Million USD | 4382.55% |
| 2020 Q1 | 1.83 Million USD | -5.37% |
| 2020 Q2 | 1.72 Million USD | -5.79% |
| 2020 FY | 77.4 Million USD | 3900.1% |
| 2020 Q4 | 77.4 Million USD | 0.1% |
| 2019 Q3 | 2.03 Million USD | -4.5% |
| 2019 Q2 | 2.13 Million USD | -6.16% |
| 2019 Q1 | 2.27 Million USD | 0.0% |
| 2019 FY | 1.93 Million USD | 0.0% |
| 2019 Q4 | 1.93 Million USD | -5.01% |
| 2018 Q3 | 41.47 Million USD | 38662.62% |
| 2018 FY | - USD | -100.0% |
| 2018 Q1 | - USD | -100.0% |
| 2018 Q2 | 107 Thousand USD | 0.0% |
| 2018 Q4 | - USD | -100.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q4 | 10.08 Million USD | 0.0% |
| 2017 FY | 10.08 Million USD | 5349.73% |
| 2016 FY | 185 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| NeuroSense Therapeutics Ltd. | 142 Thousand USD | -127809.859% |
| Psyence Biomedical Ltd. | 7.65 Million USD | -2271.981% |
| XOMA Corporation | 124.45 Million USD | -45.948% |
| Mesoblast Limited | 118.92 Million USD | -52.731% |
| Xeris Biopharma Holdings, Inc. | 229.19 Million USD | 20.751% |
| Aptorum Group Limited | 3.36 Million USD | -5301.861% |
| Qualigen Therapeutics, Inc. | 1.29 Million USD | -13880.123% |
| HilleVax, Inc. | 51.19 Million USD | -254.799% |
| Rocket Pharmaceuticals, Inc. | 25.04 Million USD | -625.309% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -769.709% |
| Precision BioSciences, Inc. | 31.26 Million USD | -480.888% |
| Dyadic International, Inc. | 136.92 Thousand USD | -132546.846% |
| Intensity Therapeutics, Inc. | 158 Thousand USD | -114856.962% |
| IDEAYA Biosciences, Inc. | 2.87 Million USD | -6224.234% |
| Eton Pharmaceuticals, Inc. | 5.45 Million USD | -3229.643% |
| VYNE Therapeutics Inc. | 214 Thousand USD | -84774.766% |
| EyePoint Pharmaceuticals, Inc. | 5.46 Million USD | -3221.119% |
| Adaptive Biotechnologies Corporation | 229.43 Million USD | 20.834% |
| Tenaya Therapeutics, Inc. | 12.42 Million USD | -1361.945% |
| IGM Biosciences, Inc. | 40.5 Million USD | -348.408% |
| Opthea Limited | 200.62 Million USD | 9.469% |
| Milestone Pharmaceuticals Inc. | 51.77 Million USD | -250.81% |
| Abeona Therapeutics Inc. | 5.4 Million USD | -3263.556% |
| Tonix Pharmaceuticals Holding Corp. | 9.81 Million USD | -1750.932% |
| Ligand Pharmaceuticals Incorporated | 6.16 Million USD | -2846.18% |
| NextCure, Inc. | 6.6 Million USD | -2649.917% |
| Inhibikase Therapeutics, Inc. | 622 Thousand USD | -29101.145% |
| Ovid Therapeutics Inc. | 46 Million USD | -294.837% |
| CASI Pharmaceuticals, Inc. | 21.23 Million USD | -755.182% |
| Arcturus Therapeutics Holdings Inc. | 30.21 Million USD | -501.112% |
| Syros Pharmaceuticals, Inc. | 62.07 Million USD | -192.601% |
| Senti Biosciences, Inc. | 37.66 Million USD | -382.217% |
| Apollomics, Inc. | 4.66 Million USD | -3796.846% |
| PureTech Health plc | 25.51 Million USD | -611.947% |
| Oncternal Therapeutics, Inc. | 318 Thousand USD | -57016.981% |
| Barinthus Biotherapeutics plc | 12.97 Million USD | -1299.753% |
| Kymera Therapeutics, Inc. | 84.67 Million USD | -114.507% |
| ChromaDex Corporation | 3.27 Million USD | -5442.63% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Akebia Therapeutics, Inc. | 104.18 Million USD | -74.341% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -376.674% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | 104.77 Million USD | -73.354% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| Fate Therapeutics, Inc. | 103.53 Million USD | -75.429% |
| BioXcel Therapeutics, Inc. | 101.38 Million USD | -79.153% |
| Fortress Biotech, Inc. | 88.59 Million USD | -105.021% |
| Checkpoint Therapeutics, Inc. | - USD | -Infinity% |
| Atossa Therapeutics, Inc. | - USD | -Infinity% |
| Lyell Immunopharma, Inc. | 63.16 Million USD | -187.543% |
| Celcuity Inc. | 37.44 Million USD | -385.047% |
| ContextLogic Inc. | 6 Million USD | -2927.2% |
| GH Research PLC | 343 Thousand USD | -52853.936% |
| HOOKIPA Pharma Inc. | 6.55 Million USD | -2669.203% |
| Cassava Sciences, Inc. | - USD | -Infinity% |
| Cyclacel Pharmaceuticals, Inc. | 37 Thousand USD | -490797.297% |
| ImmuCell Corporation | 11.96 Million USD | -1417.482% |
| Amarin Corporation plc | 8.73 Million USD | -1978.883% |
| TG Therapeutics, Inc. | 110.79 Million USD | -63.935% |
| X4 Pharmaceuticals, Inc. | 58.28 Million USD | -211.649% |
| Acelyrin, Inc. | 1.19 Million USD | -15112.06% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Seer, Inc. | 28.25 Million USD | -542.74% |
| Novavax, Inc. | 280.63 Million USD | 35.278% |
| Phathom Pharmaceuticals, Inc. | 139.03 Million USD | -30.642% |
| Jazz Pharmaceuticals plc | 5.79 Billion USD | 96.867% |
| AnaptysBio, Inc. | 17.81 Million USD | -919.603% |
| Aptevo Therapeutics Inc. | 5.39 Million USD | -3265.425% |
| PMV Pharmaceuticals, Inc. | 13.28 Million USD | -1267.093% |
| AbCellera Biologics Inc. | 77.38 Million USD | -134.727% |
| CorMedix Inc. | 667.63 Thousand USD | -27105.407% |
| Cartesian Therapeutics, Inc. | 10.95 Million USD | -1557.983% |
| Marker Therapeutics, Inc. | - USD | -Infinity% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | 93.28% |
| Aptose Biosciences Inc. | 1 Million USD | -17886.821% |
| ZyVersa Therapeutics, Inc. | 8656.00 USD | -2098236.414% |
| Soligenix, Inc. | 3.49 Million USD | -5097.563% |
| Century Therapeutics, Inc. | 48.17 Million USD | -277.057% |
| Arrowhead Pharmaceuticals, Inc. | 115.17 Million USD | -57.706% |
| TransCode Therapeutics, Inc. | 450.57 Thousand USD | -40211.516% |
| Kura Oncology, Inc. | 17.2 Million USD | -956.0% |
| RAPT Therapeutics, Inc. | 6.9 Million USD | -2530.061% |
| Ardelyx, Inc. | 55.98 Million USD | -224.447% |
| Ainos, Inc. | 5.96 Million USD | -2945.7% |
| TScan Therapeutics, Inc. | 92.43 Million USD | -96.501% |
| Ocean Biomedical, Inc. | 2.15 Million USD | -8348.0% |
| Prothena Corporation plc | 11.83 Million USD | -1434.702% |
| CytomX Therapeutics, Inc. | 13.97 Million USD | -1199.785% |
| Autolus Therapeutics plc | 52.96 Million USD | -242.915% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| Adaptimmune Therapeutics plc | 25.23 Million USD | -619.762% |
| Eterna Therapeutics Inc. | 41.84 Million USD | -334.08% |
| Celularity Inc. | 65.41 Million USD | -177.653% |
| Rallybio Corporation | 392 Thousand USD | -46234.694% |
| GRI Bio, Inc. | 14 Thousand USD | -1297271.429% |
| Xenetic Biosciences, Inc. | - USD | -Infinity% |
| Omeros Corporation | 338.28 Million USD | 46.307% |
| INmune Bio, Inc. | 10.43 Million USD | -1640.27% |
| Heron Therapeutics, Inc. | 179.62 Million USD | -1.116% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -2974.83% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -222270.225% |
| Entero Therapeutics, Inc. | 826.84 Thousand USD | -21866.901% |
| Humacyte, Inc. | 58.1 Million USD | -212.587% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -213.851% |
| Coherus BioSciences, Inc. | 480.84 Million USD | 62.226% |
| Immunocore Holdings plc | 84.03 Million USD | -116.146% |
| Cocrystal Pharma, Inc. | 1.85 Million USD | -9702.051% |
| Verastem, Inc. | 41.55 Million USD | -337.067% |
| Pliant Therapeutics, Inc. | 11.37 Million USD | -1497.186% |
| Histogen Inc. | 4.62 Million USD | -3829.727% |
| Surrozen, Inc. | 3.37 Million USD | -5275.318% |
| Blueprint Medicines Corporation | 774.12 Million USD | 76.537% |
| Organovo Holdings, Inc. | 1.39 Million USD | -12929.555% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| IO Biotech, Inc. | 2.49 Million USD | -7182.759% |
| MEI Pharma, Inc. | - USD | -Infinity% |
| GT Biopharma, Inc. | 58 Thousand USD | -313058.621% |
| Centessa Pharmaceuticals plc | 84.58 Million USD | -114.725% |
| Hepion Pharmaceuticals, Inc. | 209.02 Thousand USD | -86796.948% |
| Cabaletta Bio, Inc. | 5.01 Million USD | -3519.609% |
| Summit Therapeutics Inc. | 106.09 Million USD | -71.191% |
| Alaunos Therapeutics, Inc. | - USD | -Infinity% |
| Marinus Pharmaceuticals, Inc. | 110.35 Million USD | -64.584% |
| BioRestorative Therapies, Inc. | 162.31 Thousand USD | -111799.555% |
| Turnstone Biologics Corp. | 3.21 Million USD | -5551.276% |
| Pulmatrix, Inc. | 8.75 Million USD | -1974.372% |
| Synaptogenix, Inc. | - USD | -Infinity% |
| Tiziana Life Sciences Ltd | 247 Thousand USD | -73435.223% |
| Aurinia Pharmaceuticals Inc. | 97.6 Million USD | -86.085% |
| Vigil Neuroscience, Inc. | 13.85 Million USD | -1211.422% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -57.467% |
| Cytokinetics, Incorporated | 755.77 Million USD | 75.967% |
| Exelixis, Inc. | 189.94 Million USD | 4.376% |
| Nurix Therapeutics, Inc. | 30.61 Million USD | -493.297% |
| Apellis Pharmaceuticals, Inc. | 110.92 Million USD | -63.739% |
| Evogene Ltd. | 1.13 Million USD | -15860.633% |
| Replimune Group, Inc. | 75.86 Million USD | -139.402% |
| PDS Biotechnology Corporation | 23.85 Million USD | -661.508% |
| Hoth Therapeutics, Inc. | 55.16 Thousand USD | -329152.243% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -6419.454% |
| ESSA Pharma Inc. | 80.32 Thousand USD | -226012.937% |
| TNF Pharmaceuticals, Inc. | 48.87 Thousand USD | -371563.597% |
| BioLineRx Ltd. | 11.59 Million USD | -1467.009% |
| Avid Bioservices, Inc. | 207.83 Million USD | 12.607% |
| Insmed Incorporated | 1.2 Billion USD | 84.914% |
| VistaGen Therapeutics, Inc. | 2.12 Million USD | -8467.547% |
| Zentalis Pharmaceuticals, Inc. | 45.77 Million USD | -296.81% |
| Sagimet Biosciences Inc. | 65 Thousand USD | -279333.846% |
| MediWound Ltd. | 6.71 Million USD | -2606.482% |
| MiMedx Group, Inc. | 48.09 Million USD | -277.621% |
| OmniAb, Inc. | 25.56 Million USD | -610.583% |
| Alector, Inc. | 38.91 Million USD | -366.704% |
| Seres Therapeutics, Inc. | 213.93 Million USD | 15.1% |
| PTC Therapeutics, Inc. | 415.02 Million USD | 56.236% |
| Mereo BioPharma Group plc | 5.95 Million USD | -2951.613% |
| Zai Lab Limited | 15.15 Million USD | -1098.812% |
| Revance Therapeutics, Inc. | 478.43 Million USD | 62.036% |
| Syndax Pharmaceuticals, Inc. | 1.63 Million USD | -11008.991% |
| Aura Biosciences, Inc. | 19.55 Million USD | -828.731% |
| Immunic, Inc. | 1.33 Million USD | -13515.592% |
| Dyne Therapeutics, Inc. | 27.41 Million USD | -562.528% |
| Tarsus Pharmaceuticals, Inc. | 31.73 Million USD | -472.394% |
| Veracyte, Inc. | 12.63 Million USD | -1338.1% |
| InMed Pharmaceuticals Inc. | 644.86 Million USD | 71.834% |
| FibroGen, Inc. | 170.45 Million USD | -6.557% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -1900.132% |
| Allakos Inc. | 41.46 Million USD | -338.037% |
| scPharmaceuticals Inc. | 40.26 Million USD | -351.047% |
| Fulcrum Therapeutics, Inc. | 10.82 Million USD | -1578.514% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -120186.093% |
| Adial Pharmaceuticals, Inc. | - USD | -Infinity% |
| NLS Pharmaceutics AG | 1.63 Million USD | -11017.518% |
| Sonnet BioTherapeutics Holdings, Inc. | 203.91 Thousand USD | -88974.155% |
| Amylyx Pharmaceuticals, Inc. | 4.23 Million USD | -4186.807% |
| Precigen, Inc. | 7.09 Million USD | -2459.279% |
| Fortrea Holdings Inc. | 1.67 Billion USD | 89.176% |
| KalVista Pharmaceuticals, Inc. | 7.31 Million USD | -2382.329% |
| Incyte Corporation | 38.28 Million USD | -374.396% |
| Alzamend Neuro, Inc. | 300.71 Thousand USD | -60300.247% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -320.766% |
| XBiotech Inc. | - USD | -Infinity% |
| Aligos Therapeutics, Inc. | 11.13 Million USD | -1530.742% |
| Jasper Therapeutics, Inc. | 2.78 Million USD | -6419.454% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| CRISPR Therapeutics AG | 238.63 Million USD | 23.886% |
| Akero Therapeutics, Inc. | 26.04 Million USD | -597.431% |
| Eliem Therapeutics, Inc. | 349 Thousand USD | -51943.553% |
| Lyra Therapeutics, Inc. | 26.88 Million USD | -575.689% |
| Foghorn Therapeutics Inc. | 45.07 Million USD | -302.973% |
| Agenus Inc. | 350.24 Million USD | 48.142% |
| Kiora Pharmaceuticals, Inc. | 106.89 Thousand USD | -169822.631% |
| Y-mAbs Therapeutics, Inc. | 1.41 Million USD | -12700.0% |
| Theravance Biopharma, Inc. | 45.23 Million USD | -301.521% |
| Ultragenyx Pharmaceutical Inc. | 43.16 Million USD | -320.746% |
| Metagenomi, Inc. Common Stock | 48.22 Million USD | -276.603% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -110673.509% |
| BioCryst Pharmaceuticals, Inc. | 848.71 Million USD | 78.599% |
| UroGen Pharma Ltd. | 100.21 Million USD | -81.244% |
| Gain Therapeutics, Inc. | 1.02 Million USD | -17578.835% |
| Sutro Biopharma, Inc. | 182.74 Million USD | 0.611% |
| Creative Medical Technology Holdings, Inc. | 14.19 Thousand USD | -1279539.284% |
| Lisata Therapeutics, Inc. | 305 Thousand USD | -59451.475% |
| Chemomab Therapeutics Ltd. | 392 Thousand USD | -46234.457% |
| Stoke Therapeutics, Inc. | 6.83 Million USD | -2557.381% |
| Chimerix, Inc. | 2.14 Million USD | -8371.642% |
| Reneo Pharmaceuticals, Inc. | 973 Thousand USD | -18567.215% |
| Outlook Therapeutics, Inc. | 35.55 Million USD | -410.844% |
| 60 Degrees Pharmaceuticals, Inc. | 172.67 Thousand USD | -105088.42% |
| Pluri Inc. | 29.61 Million USD | -513.373% |
| Cue Biopharma, Inc. | 14.69 Million USD | -1136.012% |
| MeiraGTx Holdings plc | 89.26 Million USD | -103.477% |
| Aprea Therapeutics, Inc. | - USD | -Infinity% |
| Cadrenal Therapeutics, Inc. Common Stock | 21.35 Thousand USD | -850635.363% |
| Cidara Therapeutics, Inc. | 4.87 Million USD | -3624.257% |
| ProMIS Neurosciences, Inc. | - USD | -Infinity% |
| CalciMedica, Inc. | - USD | -Infinity% |
| Scholar Rock Holding Corporation | 61.81 Million USD | -193.817% |
| Sana Biotechnology, Inc. | 104.09 Million USD | -74.485% |
| Elicio Therapeutics, Inc. | 6.91 Million USD | -2525.878% |
| NLS Pharmaceutics AG | 1.63 Million USD | -11017.518% |
| Adlai Nortye Ltd. American Depositary Shares | 31.54 Million USD | -475.732% |
| Nutriband Inc. | 241.28 Thousand USD | -75176.955% |
| Protara Therapeutics, Inc. | 5.46 Million USD | -3222.334% |
| Vor Biopharma Inc. | 35.66 Million USD | -409.344% |
| Roivant Sciences Ltd. | 499.74 Million USD | 63.655% |
| ProKidney Corp. | 4.41 Million USD | -4015.84% |
| Applied Therapeutics, Inc. | 1.22 Million USD | -14715.008% |
| Daré Bioscience, Inc. | 5.31 Million USD | -3315.326% |
| BridgeBio Pharma, Inc. | 1.73 Billion USD | 89.56% |
| Titan Pharmaceuticals, Inc. | 565 Thousand USD | -32047.257% |
| Bicycle Therapeutics plc | 44.95 Million USD | -304.022% |
| Tango Therapeutics, Inc. | 38.92 Million USD | -366.68% |
| Galectin Therapeutics Inc. | 71.8 Million USD | -152.945% |
| Revolution Medicines, Inc. Warrant | 87.94 Million USD | -106.531% |
| Atai Life Sciences N.V. | 16.47 Million USD | -1002.403% |
| Renovaro Biosciences Inc. | 2.45 Million USD | -7310.538% |
| Aerovate Therapeutics, Inc. | 675 Thousand USD | -26808.444% |
| MediciNova, Inc. | 215.92 Thousand USD | -84017.707% |
| Praxis Precision Medicines, Inc. | 2.49 Million USD | -7179.84% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -14303.487% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Protagonist Therapeutics, Inc. | 1.14 Million USD | -15818.668% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | 2.543% |
| Biomea Fusion, Inc. | 10.29 Million USD | -1664.103% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Erasca, Inc. | 55.85 Million USD | -225.162% |
| Cullinan Oncology, Inc. | 3.59 Million USD | -4959.387% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -1882.666% |
| 4D Molecular Therapeutics, Inc. | 14.67 Million USD | -1138.034% |
| Kiniksa Pharmaceuticals, Ltd. | 12.25 Million USD | -1381.743% |
| bluebird bio, Inc. | 330.32 Million USD | 45.014% |
| Ventyx Biosciences, Inc. | 12.5 Million USD | -1352.359% |
| Pieris Pharmaceuticals, Inc. | - USD | -Infinity% |
| Imunon, Inc. | 1.62 Million USD | -11079.321% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | 83.981% |
| BioAtla, Inc. | 2.46 Million USD | -7283.415% |
| Allogene Therapeutics, Inc. | 95.12 Million USD | -90.948% |
| Larimar Therapeutics, Inc. | 5.54 Million USD | -3175.009% |
| DBV Technologies S.A. | 14.38 Million USD | -1163.0% |
| Fortress Biotech, Inc. | 88.59 Million USD | -105.021% |
| Avidity Biosciences, Inc. | 9.85 Million USD | -1743.605% |
| Kezar Life Sciences, Inc. | 18.93 Million USD | -859.341% |
| aTyr Pharma, Inc. | 15.09 Million USD | -1103.259% |
| Viridian Therapeutics, Inc. | 21.04 Million USD | -762.942% |
| EyeGate Pharmaceuticals, Inc. | 326.49 Thousand USD | -55531.208% |
| Galecto, Inc. | 249 Thousand USD | -72844.578% |
| Akari Therapeutics, Plc | - USD | -Infinity% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -11031.287% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | 87.885% |
| Lexicon Pharmaceuticals, Inc. | 106.06 Million USD | -71.248% |
| Entera Bio Ltd. | 390 Thousand USD | -46472.308% |
| Travere Therapeutics, Inc. | 404.78 Million USD | 55.129% |
| Sensei Biotherapeutics, Inc. | 6.2 Million USD | -2825.773% |
| Xencor, Inc. | 83.43 Million USD | -117.695% |
| Orchestra BioMed Holdings, Inc. | 1.68 Million USD | -10666.568% |
| Spruce Biosciences, Inc. | 4.6 Million USD | -3840.811% |
| Coeptis Therapeutics Holdings, Inc. | 1.22 Million USD | -14736.476% |
| Vanda Pharmaceuticals Inc. | 9.4 Million USD | -1831.433% |
| Lexaria Bioscience Corp. | 163.96 Thousand USD | -110673.509% |
| Portage Biotech Inc. | 47 Thousand USD | -386351.064% |
| Cardio Diagnostics Holdings, Inc. | 1.26 Million USD | -14303.487% |
| Olema Pharmaceuticals, Inc. | 2.41 Million USD | -7414.77% |
| OncoCyte Corporation | 2.86 Million USD | -6230.847% |
| Processa Pharmaceuticals, Inc. | 150.55 Thousand USD | -120542.427% |
| Purple Biotech Ltd. | 351 Thousand USD | -51647.009% |
| CollPlant Biotechnologies Ltd. | 3.15 Million USD | -5649.668% |
| Onconetix, Inc. | 9.88 Million USD | -1737.307% |
| MacroGenics, Inc. | 33.97 Million USD | -434.668% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | - USD | -Infinity% |
| Apogee Therapeutics, Inc. | 2.03 Million USD | -8829.798% |
| Neumora Therapeutics, Inc. Common Stock | 5.23 Million USD | -3372.223% |
| Ocuphire Pharma, Inc. | - USD | -Infinity% |
| Prime Medicine, Inc. | 13.63 Million USD | -1232.297% |
| Aditxt, Inc. | 18.21 Million USD | -896.993% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | - USD | -Infinity% |
| Savara Inc. | 26.73 Million USD | -579.303% |
| Curis, Inc. | 2.79 Million USD | -6400.787% |
| Carmell Therapeutics Corporation | 2.13 Million USD | -8401.584% |
| Adagene Inc. | 22.3 Million USD | -714.242% |
| Achieve Life Sciences, Inc. | 16.73 Million USD | -985.602% |
| BeiGene, Ltd. | 930.18 Million USD | 80.474% |
| Inhibrx Biosciences, Inc. | 210.14 Million USD | 13.567% |
| GlycoMimetics, Inc. | 808.4 Thousand USD | -22368.03% |
| Maravai LifeSciences Holdings, Inc. | 610.96 Million USD | 70.271% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| SciSparc Ltd. | 76 Thousand USD | -238889.474% |
| Protagenic Therapeutics, Inc. | - USD | -Infinity% |
| Vincerx Pharma, Inc. | 2.5 Million USD | -7159.472% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Minerva Neurosciences, Inc. | 82.01 Million USD | -121.457% |
| Fresh Tracks Therapeutics, Inc. | - USD | -Infinity% |
| Arcutis Biotherapeutics, Inc. | 205.91 Million USD | 11.793% |
| Acrivon Therapeutics, Inc. Common Stock | 4.64 Million USD | -3811.111% |
| Alnylam Pharmaceuticals, Inc. | 2.68 Billion USD | 93.229% |
| ADMA Biologics, Inc. | 141.41 Million USD | -28.436% |
| Rigel Pharmaceuticals, Inc. | 60.57 Million USD | -199.827% |
| Clene Inc. | 32.16 Million USD | -464.759% |
| Celldex Therapeutics, Inc. | 2.54 Million USD | -7045.24% |
| Cogent Biosciences, Inc. | 18.85 Million USD | -863.412% |
| Boundless Bio, Inc. Common Stock | 2.19 Million USD | -8174.806% |
| Recursion Pharmaceuticals, Inc. | 50.67 Million USD | -258.446% |
| Adicet Bio, Inc. | 20.92 Million USD | -768.056% |
| Contineum Therapeutics, Inc. Class A Common Stock | 193.19 Million USD | 5.984% |
| Absci Corporation | 15.95 Million USD | -1038.259% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 15.3 Million USD | -1086.905% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 20.29 Million USD | -795.048% |
| Surrozen, Inc. | 3.37 Million USD | -5275.318% |
| Generation Bio Co. | 97.89 Million USD | -85.539% |
| Astria Therapeutics, Inc. | 329 Thousand USD | -55107.295% |
| Caribou Biosciences, Inc. | 27.48 Million USD | -560.84% |
| Black Diamond Therapeutics, Inc. | 25.29 Million USD | -617.97% |
| Janux Therapeutics, Inc. | 24.54 Million USD | -640.086% |
| Invivyd, Inc. | 2.16 Million USD | -8289.469% |
| Cingulate Inc. | 3.13 Million USD | -5693.501% |
| Relay Therapeutics, Inc. | 53.46 Million USD | -239.715% |
| Quoin Pharmaceuticals, Ltd. | 3523.73 USD | -5154437.947% |
| Tenax Therapeutics, Inc. | 500.9 Thousand USD | -36160.913% |
| Spero Therapeutics, Inc. | 5.54 Million USD | -3176.782% |
| Jaguar Health, Inc. | 35.86 Million USD | -406.503% |
| Artelo Biosciences, Inc. | 63 Thousand USD | -288204.762% |
| 2seventy bio, Inc. | 256.67 Million USD | 29.236% |
| Clearside Biomedical, Inc. | 43 Million USD | -322.39% |
| Terns Pharmaceuticals, Inc. | 603 Thousand USD | -30021.393% |
| ACADIA Pharmaceuticals Inc. | 57.2 Million USD | -217.511% |
| Capricor Therapeutics, Inc. | 5.61 Million USD | -3136.404% |
| Citius Pharmaceuticals, Inc. | 481.24 Thousand USD | -37642.106% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Kronos Bio, Inc. | 28.27 Million USD | -542.445% |
| Innoviva, Inc. | 449.07 Million USD | 59.554% |
| Bolt Biotherapeutics, Inc. | 20.21 Million USD | -798.323% |
| Entrada Therapeutics, Inc. | 68.23 Million USD | -166.205% |
| ALX Oncology Holdings Inc. | 17.19 Million USD | -956.184% |
| Vir Biotechnology, Inc. | 124.54 Million USD | -45.842% |
| Evaxion Biotech A/S | 10.86 Million USD | -1570.997% |
| Ocular Therapeutix, Inc. | 83.38 Million USD | -117.813% |
| Verve Therapeutics, Inc. | 74.9 Million USD | -142.477% |
| Tyra Biosciences, Inc. | 6.49 Million USD | -2696.059% |
| Galmed Pharmaceuticals Ltd. | 41 Thousand USD | -442904.878% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -572.96% |
| Connect Biopharma Holdings Limited | 465 Thousand USD | -38960.645% |
| Clearmind Medicine Inc. | - USD | -Infinity% |
| AlloVir, Inc. | 27.42 Million USD | -562.19% |
| ORIC Pharmaceuticals, Inc. | 10.21 Million USD | -1678.439% |
| Catalyst Pharmaceuticals, Inc. | 3.55 Million USD | -5006.326% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -11580.514% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -14315.238% |
| Keros Therapeutics, Inc. | 14.44 Million USD | -1157.491% |
| SELLAS Life Sciences Group, Inc. | 906 Thousand USD | -19947.682% |
| Crinetics Pharmaceuticals, Inc. | 51.72 Million USD | -251.129% |
| ImmunityBio, Inc. | 883.67 Million USD | 79.446% |
| Korro Bio, Inc. | 33.2 Million USD | -446.969% |
| C4 Therapeutics, Inc. | 70.97 Million USD | -155.906% |
| Kineta, Inc. | 1.31 Million USD | -13691.344% |
| Lantern Pharma Inc. | 234.47 Thousand USD | -77364.591% |
| BioVie Inc. | 6.11 Million USD | -2871.997% |
| Codexis, Inc. | 22.36 Million USD | -712.162% |
| Celularity Inc. | 65.41 Million USD | -177.653% |
| Eledon Pharmaceuticals, Inc. | 383 Thousand USD | -47323.499% |
| Virax Biolabs Group Limited | 224.3 Thousand USD | -80877.263% |
| Cibus, Inc. | 24.62 Million USD | -637.712% |
| Annexon, Inc. | 31.35 Million USD | -479.276% |
| Assembly Biosciences, Inc. | 2.34 Million USD | -7655.423% |
| Moderna, Inc. | - USD | -Infinity% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | 87.504% |
| Adverum Biotechnologies, Inc. | 75.03 Million USD | -142.06% |
| Avalo Therapeutics, Inc. | 3.9 Million USD | -4553.651% |
| Immix Biopharma, Inc. | - USD | -Infinity% |
| Eyenovia, Inc. | 16.1 Million USD | -1027.606% |
| Puma Biotechnology, Inc. | 111.49 Million USD | -62.913% |
| Monte Rosa Therapeutics, Inc. | 46.03 Million USD | -294.518% |
| Wave Life Sciences Ltd. | 32.11 Million USD | -465.515% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -18339.797% |
| Xilio Therapeutics, Inc. | 11.45 Million USD | -1485.336% |
| Alkermes plc | 290.73 Million USD | 37.526% |
| Arcellx, Inc. | 97.62 Million USD | -86.051% |
| Moolec Science SA | 2.64 Million USD | -6766.244% |
| Cardiff Oncology, Inc. | 2.14 Million USD | -8351.931% |
| LAVA Therapeutics N.V. | 6.31 Million USD | -2777.111% |
| Enanta Pharmaceuticals, Inc. | 26.51 Million USD | -585.068% |
| Regulus Therapeutics Inc. | 3.1 Million USD | -5755.319% |
| Atea Pharmaceuticals, Inc. | 2.4 Million USD | -7461.699% |
| Compass Therapeutics, Inc. | 1.73 Million USD | -10380.785% |
| Greenwich LifeSciences, Inc. | - USD | -Infinity% |
| Humacyte, Inc. | 58.1 Million USD | -212.587% |
| Acumen Pharmaceuticals, Inc. | 28.48 Million USD | -537.596% |
| Geron Corporation | 85.89 Million USD | -111.448% |
| Verrica Pharmaceuticals Inc. | 45.51 Million USD | -299.103% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Royalty Pharma plc | 6.13 Billion USD | 97.04% |
| TFF Pharmaceuticals, Inc. | 115.25 Thousand USD | -157492.795% |
| Notable Labs, Ltd. | 2.04 Million USD | -8764.422% |
| Mersana Therapeutics, Inc. | 33.83 Million USD | -436.896% |
| Structure Therapeutics Inc. | 5.45 Million USD | -3230.863% |
| IN8bio, Inc. | 4.89 Million USD | -3612.078% |
| 89bio, Inc. | 27.1 Million USD | -570.031% |
| DiaMedica Therapeutics Inc. | 400 Thousand USD | -45308.0% |
| Vera Therapeutics, Inc. | 53.7 Million USD | -238.184% |
| Acasti Pharma Inc. | - USD | -Infinity% |
| Genelux Corporation | 2.51 Million USD | -7110.48% |
| Trevi Therapeutics, Inc. | 1.33 Million USD | -13474.888% |
| Liquidia Corporation | 3.5 Million USD | -5085.041% |
| Mustang Bio, Inc. | 2.49 Million USD | -7171.097% |
| Immunovant, Inc. | 138 Thousand USD | -131517.391% |
| Vericel Corporation | 88.14 Million USD | -106.065% |
| Quantum-Si incorporated | 15.3 Million USD | -1086.905% |
| Arbutus Biopharma Corporation | 8.72 Million USD | -1982.697% |
| XOMA Corporation | 124.45 Million USD | -45.948% |
| ARS Pharmaceuticals, Inc. | 274 Thousand USD | -66189.051% |
| MiNK Therapeutics, Inc. | - USD | -Infinity% |
| Pasithea Therapeutics Corp. | 81.68 Thousand USD | -222270.225% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1268.123% |
| Vaxcyte, Inc. | 29.22 Million USD | -521.517% |
| Xenon Pharmaceuticals Inc. | 10.9 Million USD | -1565.89% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| NeuroBo Pharmaceuticals, Inc. | 203 Thousand USD | -89373.892% |
| Tempest Therapeutics, Inc. | 20.66 Million USD | -779.106% |
| Sol-Gel Technologies Ltd. | 1.65 Million USD | -10888.022% |
| Rhythm Pharmaceuticals, Inc. | 1.26 Million USD | -14315.238% |
| Soleno Therapeutics, Inc. | 403 Thousand USD | -44969.975% |
| Enlivex Therapeutics Ltd. | 1.03 Million USD | -17500.0% |
| PepGen Inc. | 20.1 Million USD | -803.462% |
| Moleculin Biotech, Inc. | 574 Thousand USD | -31543.206% |
| United Therapeutics Corporation | 700 Million USD | 74.053% |
| Solid Biosciences Inc. | 26.26 Million USD | -591.536% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Conduit Pharmaceuticals Inc. | 985 Thousand USD | -18339.797% |
| Immuneering Corporation | 4.46 Million USD | -3969.766% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | - USD | -Infinity% |
| Telomir Pharmaceuticals, Inc. Common Stock | 101 Thousand USD | -179733.663% |
| Belite Bio, Inc | 886 Thousand USD | -20400.226% |
| Pharming Group N.V. | 171.54 Million USD | -5.88% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bionomics Limited | 239.61 Million USD | 24.199% |
| Pyxis Oncology, Inc. | 21.33 Million USD | -751.493% |
| uniQure N.V. | 138.4 Million USD | -31.228% |
| Windtree Therapeutics, Inc. | 16.83 Million USD | -979.216% |
| GeoVax Labs, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | 85.42 Million USD | -112.627% |
| Altimmune, Inc. | 671 Thousand USD | -26968.852% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | 13.27 Million USD | -1268.123% |
| Peak Bio, Inc. | 10.72 Million USD | -1594.043% |
| SeaStar Medical Holding Corporation | 9.08 Million USD | -1900.132% |
| FibroBiologics, Inc. Common Stock | 1.74 Million USD | -10296.795% |
| Benitec Biopharma Inc. | 284 Thousand USD | -63854.93% |
| Zura Bio Limited | - USD | -Infinity% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | 59.189% |
| Salarius Pharmaceuticals, Inc. | 289.64 Thousand USD | -62608.921% |
| Compugen Ltd. | 1.35 Million USD | -13344.264% |
| Elevai Labs, Inc. Common Stock | 210.48 Thousand USD | -86190.495% |
| argenx SE | 20 Million USD | -808.16% |
| Zevra Therapeutics, Inc. | 42.76 Million USD | -324.711% |
| Nuvectis Pharma, Inc. | - USD | -Infinity% |
| Spyre Therapeutics, Inc. | 84.55 Million USD | -114.809% |
| NKGen Biotech, Inc. Common Stock | 19.92 Million USD | -811.761% |
| Madrigal Pharmaceuticals, Inc. | 117.19 Million USD | -54.985% |
| PolyPid Ltd. | 11.77 Million USD | -1441.998% |
| Aileron Therapeutics, Inc. | 91.45 Million USD | -98.596% |
| Plus Therapeutics, Inc. | 4.18 Million USD | -4244.224% |
| Forte Biosciences, Inc. | - USD | -Infinity% |
| Dianthus Therapeutics, Inc. | 585 Thousand USD | -30948.205% |
| Instil Bio, Inc. | 86.05 Million USD | -111.067% |
| Elevation Oncology, Inc. | 30.13 Million USD | -502.688% |
| Immunome, Inc. | 1.65 Million USD | -10908.0% |
| Verona Pharma plc | 51.32 Million USD | -253.858% |
| Enveric Biosciences, Inc. | - USD | -Infinity% |
| enGene Holdings Inc. Warrants | 9.77 Million USD | -1757.558% |
| Shattuck Labs, Inc. | 4.2 Million USD | -4222.513% |
| LENZ Therapeutics, Inc. | 362 Thousand USD | -50074.586% |
| Design Therapeutics, Inc. | 3.05 Million USD | -5855.148% |
| Leap Therapeutics, Inc. | 262 Thousand USD | -69225.191% |
| Seelos Therapeutics, Inc. | 14.22 Million USD | -1176.581% |
| Achilles Therapeutics plc | 4.61 Million USD | -3835.688% |
| Fractyl Health, Inc. Common Stock | 373.72 Million USD | 51.399% |
| Rani Therapeutics Holdings, Inc. | 30.09 Million USD | -503.449% |
| MoonLake Immunotherapeutics | 3.69 Million USD | -4811.806% |
| Beam Therapeutics Inc. | 173.17 Million USD | -4.885% |
| Moolec Science SA | 2.64 Million USD | -6766.244% |
| Longboard Pharmaceuticals, Inc. | 475 Thousand USD | -38138.316% |
| AEON Biopharma, Inc. | 278 Thousand USD | -65235.252% |
| Aadi Bioscience, Inc. | 7.02 Million USD | -2485.877% |
| Enliven Therapeutics, Inc. | 335 Thousand USD | -54118.507% |
| Iovance Biotherapeutics, Inc. | 75.86 Million USD | -139.424% |
| Taysha Gene Therapies, Inc. | 61.1 Million USD | -197.236% |
| Inovio Pharmaceuticals, Inc. | 30.2 Million USD | -501.246% |
| Athira Pharma, Inc. | 1.58 Million USD | -11359.432% |
| HCW Biologics Inc. | 6.45 Million USD | -2715.224% |
| XOMA Corporation | 124.45 Million USD | -45.948% |
| NeurAxis, Inc. | 224.26 Thousand USD | -80891.706% |
| Lumos Pharma, Inc. | 6.58 Million USD | -2658.269% |
| enGene Holdings Inc. Common Stock | 9.77 Million USD | -1757.558% |
| 180 Life Sciences Corp. | 1.32 Million USD | -13659.281% |
| Nektar Therapeutics | 230.4 Million USD | 21.167% |
| NKGen Biotech, Inc. Warrants | 19.92 Million USD | -811.761% |
| Opiant Pharmaceuticals, Inc. | 17.08 Million USD | -963.412% |
| Arvinas, Inc. | 3.4 Million USD | -5242.118% |
| CERo Therapeutics Holdings, Inc. | 1.55 Million USD | -11580.514% |
| Palisade Bio, Inc. | 369 Thousand USD | -49122.764% |
| Nutriband Inc. | 241.28 Thousand USD | -75176.955% |
| Tevogen Bio Holdings Inc. | 1.63 Million USD | -11031.287% |
| CG Oncology, Inc. Common stock | 826 Thousand USD | -21889.346% |
| Tourmaline Bio, Inc. | 415 Thousand USD | -43666.747% |
| Merus N.V. | 12.16 Million USD | -1393.439% |
| Omega Therapeutics, Inc. | 128.42 Million USD | -41.427% |
| Neurogene Inc. | 16.25 Million USD | -1017.392% |
| Mirum Pharmaceuticals, Inc. | 308.14 Million USD | 41.056% |
| Kintara Therapeutics, Inc. | - USD | -Infinity% |
| CervoMed Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | 28.54 Million USD | -536.39% |
| Sesen Bio, Inc. | - USD | -Infinity% |
| Quince Therapeutics, Inc. | 13.81 Million USD | -1214.84% |
| Rezolute, Inc. | 2.22 Million USD | -8052.244% |
| Clene Inc. | 32.16 Million USD | -464.759% |
| Indaptus Therapeutics, Inc. | 175.05 Thousand USD | -103658.29% |
| BeyondSpring Inc. | 3.99 Million USD | -4446.483% |
| Synlogic, Inc. | 17.27 Million USD | -951.415% |
| Allarity Therapeutics, Inc. | 1.3 Million USD | -13871.692% |
| Phio Pharmaceuticals Corp. | 35 Thousand USD | -518848.571% |
| Peak Bio, Inc. | 10.72 Million USD | -1594.043% |
| Werewolf Therapeutics, Inc. | 51.92 Million USD | -249.81% |
| Krystal Biotech, Inc. | 8.09 Million USD | -2144.033% |
| Karyopharm Therapeutics Inc. | 177.01 Million USD | -2.608% |
| SpringWorks Therapeutics, Inc. | 7.05 Million USD | -2473.785% |
| Lipella Pharmaceuticals Inc. | 136.59 Thousand USD | -132872.166% |
| MannKind Corporation | 382.37 Million USD | 52.499% |
| Ikena Oncology, Inc. | 10.73 Million USD | -1591.488% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 409 Thousand USD | -44308.802% |
| Gossamer Bio, Inc. | 212.46 Million USD | 14.512% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | 174 Thousand USD | -104286.207% |
| NRx Pharmaceuticals, Inc. | 9.16 Million USD | -1882.666% |
| Legend Biotech Corporation | 328.67 Million USD | 44.738% |
| Mural Oncology plc | 15 Million USD | -1110.154% |
| Disc Medicine, Inc. | 2.1 Million USD | -8545.026% |
| Champions Oncology, Inc. | 7.43 Million USD | -2344.576% |
| REGENXBIO Inc. | 89.29 Million USD | -103.418% |
| Ensysce Biosciences, Inc. | 854.69 Thousand USD | -21151.04% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | 552.98 Thousand USD | -32745.915% |
| Edgewise Therapeutics, Inc. | 5.41 Million USD | -3254.858% |
| Vaxart, Inc. | 26.51 Million USD | -585.042% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | 15.65 Million USD | -1060.042% |
| Cellectis S.A. | 92.85 Million USD | -95.612% |
| Longeveron Inc. | 2.04 Million USD | -8799.167% |
| Repare Therapeutics Inc. | 3.41 Million USD | -5226.452% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | 86.997% |
| Inozyme Pharma, Inc. | 46.59 Million USD | -289.835% |
| Revolution Medicines, Inc. | 87.94 Million USD | -106.531% |
| Nymox Pharmaceutical Corporation | 173 Thousand USD | -104889.595% |
| Third Harmonic Bio, Inc. | 3.95 Million USD | -4494.789% |
| ArriVent BioPharma, Inc. Common Stock | 317 Thousand USD | -57197.161% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 175 Thousand USD | -103689.714% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | 77.532% |
| Denali Therapeutics Inc. | 52.24 Million USD | -247.681% |
| Revelation Biosciences, Inc. | - USD | -Infinity% |
| Veru Inc. | 14.4 Million USD | -1160.855% |
| Corvus Pharmaceuticals, Inc. | 1.37 Million USD | -13119.214% |
| Cingulate Inc. | 3.13 Million USD | -5693.501% |
| Passage Bio, Inc. | 26.29 Million USD | -590.774% |
| Context Therapeutics Inc. | - USD | -Infinity% |
| Exicure, Inc. | 6.66 Million USD | -2625.161% |
| Day One Biopharmaceuticals, Inc. | 408 Thousand USD | -44417.647% |
| Oramed Pharmaceuticals Inc. | 894 Thousand USD | -20216.779% |
| Scinai Immunotherapeutics Ltd. | 20.56 Million USD | -783.381% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | 2.45 Million USD | -7310.16% |
| Carisma Therapeutics, Inc. | 3.12 Million USD | -5715.946% |
| Unicycive Therapeutics, Inc. | 811 Thousand USD | -22296.054% |
| OmniAb, Inc. | 25.56 Million USD | -610.583% |
| Anew Medical, Inc. | 1.6 Million USD | -11216.636% |
| Fennec Pharmaceuticals Inc. | 29.58 Million USD | -513.977% |
| Lipocine Inc. | 17.16 Thousand USD | -1057991.576% |
| Lexeo Therapeutics, Inc. Common Stock | 11.63 Million USD | -1460.681% |
| Nautilus Biotechnology, Inc. | 34.62 Million USD | -424.524% |
| SAB Biotherapeutics, Inc. | 5.9 Million USD | -2974.83% |
| G1 Therapeutics, Inc. | 57.17 Million USD | -217.688% |
| Bellerophon Therapeutics, Inc. | 203 Thousand USD | -89373.892% |
| Sage Therapeutics, Inc. | 5.16 Million USD | -3416.592% |
| Ocugen, Inc. | 6.94 Million USD | -2516.799% |
| Mind Medicine (MindMed) Inc. | 14.12 Million USD | -1185.526% |
| Q32 Bio Inc. | 1.31 Million USD | -13680.88% |
| Brainstorm Cell Therapeutics Inc. | 672 Thousand USD | -26928.571% |
| Alumis Inc. Common Stock | 32.58 Million USD | -457.495% |
| Equillium, Inc. | 824 Thousand USD | -21942.718% |
| Kyverna Therapeutics, Inc. | 9.07 Million USD | -1900.573% |
| Coya Therapeutics, Inc. | - USD | -Infinity% |
| CNS Pharmaceuticals, Inc. | 300.8 Thousand USD | -60281.774% |
| Dominari Holdings Inc. | 3.02 Million USD | -5898.415% |
| Edesa Biotech, Inc. | 94.48 Thousand USD | -192129.619% |
| vTv Therapeutics Inc. | 529 Thousand USD | -34234.972% |
| Bio-Techne Corporation | 419.53 Million USD | 56.707% |
| Agios Pharmaceuticals, Inc. | 71.99 Million USD | -152.281% |
| Harmony Biosciences Holdings, Inc. | 193.56 Million USD | 6.165% |
| Prelude Therapeutics Incorporated | 16.88 Million USD | -975.509% |
| Candel Therapeutics, Inc. | 22.76 Million USD | -697.962% |
| iTeos Therapeutics, Inc. | 6.05 Million USD | -2898.217% |
| Nkarta, Inc. | 88.33 Million USD | -105.608% |
| BioCardia, Inc. | 1.31 Million USD | -13712.319% |
| Iterum Therapeutics plc | 19.5 Million USD | -831.016% |